US EditionCan this Company Break the Financial Barrier to Biomanufacturing?
Summary by C3 Solutions
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Can this Company Break the Financial Barrier to Biomanufacturing?
From innovative vaccines to cell-based meats, bioproducts are a rapidly growing market. In fact, the bioproducts market will surge to $200 billion by 2040. However, according to a report from Synonym and the Boston Consulting Group, for the industry to reach this demand, biomanufacturing capacity must grow twentyfold from its current level. The economy or the climate? Why not both? Subscribe for idea…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
